| Publishes | Bi-weekly | Episodes | 100 | Founded | N/A |
|---|---|---|---|---|---|
| Number of Listeners | Category | Science | |||
Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Thu Dec 18 2025
Combination regimens improve survival in advanced EGFR-mutated NSCLC, but they also increase toxicity. Jorge Nieva, MD, shares how he talks with patients about potential adverse events. He describes the options available for prophylaxis and how he treats the toxicities that do arise.
Public ranges are rounded for privacy. Unlock the full report for exact values.
Social links
No public profiles listed.
We publicly share enough context for discovery. For actionable outreach data, unlock the private blocks below.
Want to get booked on podcasts like this?
PodPitch helps you find shows, draft personalized pitches, and hit send faster. We share enough public context for discovery; for actionable outreach data, unlock the private blocks.
This show is Rank #49870 by pitch volume, with 5 pitches sent by PodPitch users.
We summarize public review counts here; full review text aggregation is not shown on PodPitch yet.
Peer-Spectives is a podcast series that is moderated by Robert Figlin, MD, and features various oncology thought-leaders covering the latest clinical developments in a wide range of tumor types.
Bi-weekly
PodPitch shows a public audience band (like "Under 4K / month"). Book a demo to unlock exact audience estimates and how we calculate them.
Use PodPitch to access verified outreach details and pitch recommendations for OBR Peer-Spectives. Start at https://podpitch.com/try/1.
This page includes internal links to similar podcasts. You can also browse the full directory at https://podpitch.com/podcasts.
Public pages only show a masked contact preview. Book a demo to unlock verified email and outreach fields.